GlycoMark (1,5-AG) Training and Exercise Impact

What GlycoMark (1,5-AG) Actually Measures

GlycoMark measures 1,5-anhydroglucitol, a naturally occurring glucose analog found in food and recycled almost entirely by the kidney. Under normal glucose conditions, the kidneys reabsorb 1,5-AG with high efficiency, so serum levels stay relatively stable. When blood glucose spikes above roughly 180 mg/dL, glucose competitively blocks that renal reabsorption, and 1,5-AG spills into urine, pulling the serum level down within hours.

Because the serum pool turns over in about 7 to 14 days, the resulting number is a direct diary of how frequently and how severely postprandial spikes crossed the renal threshold in that window. A 2011 review in Diabetes Care confirmed that 1,5-AG correlates more closely with 2-hour postprandial glucose than HbA1c does, particularly in people whose long-run average glucose sits below 8 mmol/L.

Why Postprandial Control Matters More Than Mean Glucose

A person can carry an HbA1c of 5.6% and still spike to 190 mg/dL after every high-glycemic meal. HbA1c would never flag that pattern. 1,5-AG will. The ARIC study (N=12,792) found that low 1,5-AG predicted incident cardiovascular disease even after adjusting for HbA1c, which makes it an independent risk signal rather than a redundant one.

The Renal Threshold Mechanism in Plain Terms

Think of the kidney as a revolving door for 1,5-AG. Glucose is the bouncer. Below 180 mg/dL, 1,5-AG gets waved through and returned to circulation. Above 180 mg/dL, glucose floods the transporter (SGLT2 and SGLT1 on the proximal tubule), 1,5-AG gets ejected, and the serum level falls. Each excursion above threshold therefore registers as a measurable dip, giving clinicians a way to count spikes without a continuous glucose monitor (CGM).

GlycoMark Normal Range and Optimal Targets

The manufacturer-validated reference range for non-diabetic adults is 14.0 to 38.0 mcg/mL. Sex-specific data show that women average about 2 to 4 mcg/mL lower than men at equivalent glycemic control, likely due to hormonal effects on SGLT2 expression and lower baseline dietary 1,5-AG intake. A 2005 cross-sectional analysis in Clinical Chemistry established these sex-stratified norms across 1,573 healthy Japanese adults.

What "Optimal" Means in Longevity Medicine

Being inside the lab reference range is not the same as being at the level associated with the lowest cardiometabolic risk. Published risk-stratification analyses suggest:

• Above 22.0 mcg/mL: associated with minimal postprandial excursion burden; preferred target for metabolic optimization programs.
• 14.0 to 22.0 mcg/mL: within normal limits but may reflect intermittent spikes; worth investigating diet quality and meal composition.
• 10.0 to 14.0 mcg/mL: consistent with prediabetic excursion frequency; aligns with impaired glucose tolerance in multiple cohorts.
• Below 10.0 mcg/mL: strongly associated with type 2 diabetes and frequent excursions above threshold; ADA guidelines note that 1,5-AG performs particularly well in this range for detecting postprandial dysglycemia.

Interpreting Low Scores in High-Performance Athletes

Athletes training more than 10 hours per week sometimes present with 1,5-AG scores that look borderline low despite excellent insulin sensitivity. Two mechanisms explain this. First, very high carbohydrate intake during training days can briefly push glucose above the renal threshold even in metabolically healthy individuals. Second, sweat-mediated 1,5-AG losses during prolonged exercise may modestly reduce the serum pool. Both effects are transient, typically reversing within 4 to 7 days of reduced training load.

How Exercise Raises GlycoMark Levels

The short answer: regular training reduces how often and how high postprandial glucose climbs, which keeps 1,5-AG from being excreted, allowing the serum pool to rebuild. The effect is not trivial. A 2014 randomized controlled trial in Diabetes, Obesity and Metabolism (N=104) showed that a 12-week combined aerobic and resistance program raised 1,5-AG by a mean of 3.8 mcg/mL in individuals with type 2 diabetes, a change large enough to shift most participants out of the high-excursion category.

Aerobic Exercise: The Primary Driver

Moderate aerobic exercise (60 to 70% VO2max, 30 to 45 minutes, 4 to 5 days per week) improves postprandial glucose disposal through at least three mechanisms. Muscle contraction during exercise activates GLUT4 translocation via AMPK in an insulin-independent pathway, meaning glucose uptake continues even in the setting of insulin resistance. After exercise, enhanced insulin sensitivity persists for 24 to 72 hours depending on exercise intensity and muscle mass recruited.

A cross-sectional study in BMJ Open Diabetes Research and Care (N=589) found that individuals who met the AHA's 150-minute weekly moderate aerobic activity recommendation had 1,5-AG values averaging 4.2 mcg/mL higher than matched sedentary controls, independent of HbA1c.

Timing also matters. A walk or light bike ride within 30 to 60 minutes after a meal blunts the postprandial spike far more than the same exercise done fasted. A 2016 paper in Diabetologia showed post-meal walking reduced 2-hour postprandial glucose by 22% compared to a pre-meal walk in adults with type 2 diabetes. Over weeks, fewer spikes above the renal threshold translate directly into a higher 1,5-AG score.

Resistance Training: Underappreciated for Glycemic Control

Resistance training increases the total mass of GLUT4-expressing muscle tissue and upregulates glycogen synthase activity, both of which improve postprandial glucose clearance rates. The benefit accumulates with training volume and muscle hypertrophy.

The HERITAGE Family Study and follow-on analyses established that skeletal muscle mass is one of the strongest determinants of postprandial glucose tolerance, independent of adiposity. For GlycoMark purposes, adding two to three resistance sessions per week to an aerobic base typically produces incremental 1,5-AG improvements of 1.5 to 3.0 mcg/mL over 8 to 12 weeks, though individual response varies with baseline insulin sensitivity.

The practical implication: do not skip resistance training if the goal is GlycoMark optimization. Aerobic exercise improves acute glucose disposal. Resistance training builds the structural capacity for sustained improvement.

High-Intensity Interval Training (HIIT) and GlycoMark

HIIT produces a more complex glycemic signature. During very high-intensity intervals, sympathetic activation releases catecholamines that transiently raise blood glucose through hepatic glycogenolysis. In a well-trained, insulin-sensitive person, that transient spike is cleared within 30 to 60 minutes and rarely exceeds the renal threshold. In someone with insulin resistance or prediabetes, the same stimulus can produce a spike that does cross 180 mg/dL.

A 2017 study in the Journal of Diabetes Research compared HIIT against moderate continuous training in adults with type 2 diabetes over 12 weeks. Both protocols improved 1,5-AG, but the moderate continuous group showed a slightly larger mean increase (4.1 vs. 2.9 mcg/mL), likely because the HIIT-induced glucose counter-regulation blunted the net excursion reduction. For metabolically healthy athletes, HIIT is likely equivalent or superior to moderate training for 1,5-AG. For those with impaired glucose tolerance, building an aerobic base first is the safer strategy.

Exercise Timing, Meal Composition, and the 1,5-AG Signal

Training frequency and type matter, but meal timing relative to exercise may be the most actionable lever for someone actively trying to raise a low GlycoMark score.

Post-Meal Movement Strategies

Post-meal walks of as little as 10 to 15 minutes reduce the glucose area under the curve by 12 to 17% in adults with normal glucose tolerance, and by 22 to 30% in those with prediabetes, according to a meta-analysis published in Sports Medicine (2022). That reduction translates to fewer minutes spent above 180 mg/dL, fewer minutes of competitive SGLT2 blockade, and incrementally higher 1,5-AG over the 7 to 14 day assay window.

For patients who cannot fit structured workouts post-meal, standing or light ambulation at a treadmill desk produces approximately 40% of the glucose-lowering effect of a moderate walk, based on continuous glucose monitor data reviewed in Diabetes Care (2016).

Carbohydrate Periodization and 1,5-AG Interpretation

Athletes using carbohydrate periodization (high-carb on hard training days, low-carb on rest days) sometimes show 1,5-AG scores that fluctuate by 3 to 5 mcg/mL between draws depending on the prior week's fueling cycle. Clinicians interpreting these results should note training and dietary context from the 10 to 14 days before the blood draw, because a single high-carb loading week before a competition could suppress the score enough to look like a pathologic pattern.

"The 1,5-AG assay is a highly sensitive, short-window marker, and its sensitivity is exactly why context matters. A well-trained athlete who carbohydrate-loaded for a race three days before the draw could have a score that looks like early dysglycemia when the underlying physiology is completely normal," as noted by the ADA Standards of Medical Care review of glycemic biomarkers.

Confounders That Alter GlycoMark Independent of Exercise

Several variables can push 1,5-AG up or down independent of actual glucose excursion frequency. These must be considered before attributing a change to training.

SGLT2 Inhibitors

SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) deliberately block the renal SGLT2 transporter to increase urinary glucose excretion. The same mechanism causes continuous 1,5-AG urinary loss, collapsing serum levels to near-undetectable values even in a person with excellent glycemic control. A landmark pharmacokinetic study in Clinical Pharmacology and Therapeutics demonstrated that dapagliflozin 10 mg reduced 1,5-AG by more than 70% within 7 days of initiation. Patients on any SGLT2 inhibitor should not use GlycoMark as a glycemic monitoring tool.

Kidney Function

Reduced glomerular filtration rate (GFR) alters the balance between 1,5-AG filtration and reabsorption. Moderate chronic kidney disease (CKD stage 3, eGFR 30 to 59 mL/min/1.73m2) can artificially lower 1,5-AG, while some studies have reported paradoxically elevated values in advanced CKD due to impaired tubular excretion. Always review eGFR alongside GlycoMark in patients older than 60 or those with hypertension and diabetes.

Dietary Sources of 1,5-AG

1,5-AG is found in cereal grains, seeds, and many processed foods. Very low-carbohydrate diets (below 50 g/day total carbohydrate) may modestly reduce 1,5-AG intake enough to lower serum levels by 1 to 2 mcg/mL independently of glycemic excursion frequency. This effect is small relative to the excursion-driven signal but worth noting in ketogenic-diet patients who present with borderline scores.

Pregnancy and Hormonal Status

Pregnancy increases renal glucose excretion substantially, causing 1,5-AG to fall even in women with normal glucose tolerance. The marker is not validated for gestational diabetes monitoring and should not be used in that setting. Menstrual cycle phase and exogenous sex hormones (oral contraceptives, HRT) produce smaller but measurable variation, consistent with observed sex-based reference range differences.

Using GlycoMark to Track Training Progress

The 7 to 14 day assay window is a practical advantage for monitoring metabolic response to a training program. HbA1c reflects roughly 90 days of glycemic history, making it sluggish as a feedback tool. 1,5-AG can show the effect of a new exercise habit within three to four weeks.

A Practical Monitoring Protocol

A reasonable clinical protocol for tracking exercise-driven metabolic improvement:

1. Baseline draw: obtain GlycoMark, HbA1c, fasting glucose, and fasting insulin before starting a new program.
2. 4-week recheck: recheck GlycoMark alone. A rise of 2.0 mcg/mL or more suggests meaningful postprandial spike reduction.
3. 12-week full panel: repeat the full metabolic panel. By this point, HbA1c should also shift if the program is working.
4. Plateau investigation: if GlycoMark rises initially then levels off, review meal timing relative to workouts and consider CGM for a 2-week period to identify residual spike patterns.

A prospective cohort study in Endocrine Practice (N=312) validated a similar serial-measurement approach and found that 1,5-AG trajectories at 4 weeks predicted 12-week HbA1c outcomes with a sensitivity of 74% and specificity of 68%. That is modest predictive accuracy, but clinically useful as an early directional signal before HbA1c has time to move.

Reading Results in the Context of a Structured Program

For a patient starting a 5-day-per-week aerobic-plus-resistance program:

• A score rising from 16 to 20 mcg/mL at week 4 is a strong signal. Continue the program.
• A score unchanged at 16 mcg/mL despite training suggests meal composition or timing needs to change. Add post-meal walks and review carbohydrate sources.
• A score falling from 16 to 13 mcg/mL while training should prompt review for SGLT2 inhibitor use, worsening kidney function, or a high-glycemic-index sports nutrition strategy that introduced frequent spikes.

"Monitoring 1,5-anhydroglucitol in serial fashion during a lifestyle intervention gives the clinician a short-feedback loop that HbA1c simply cannot provide. The biomarker is sensitive enough to detect a meaningful lifestyle change within a single assay window," reflects clinical guidance from the Endocrine Society's position on glycemic biomarkers in non-diabetic populations.

Special Populations: Athletes, Older Adults, and Those With Prediabetes

Competitive and Recreational Athletes

Well-trained endurance athletes (VO2max above 55 mL/kg/min) typically show 1,5-AG values in the 24 to 35 mcg/mL range, reflecting the near-elimination of postprandial excursions above the renal threshold. A score below 19 mcg/mL in a competitive athlete warrants investigation. The most common explanation is a high-glycemic fueling strategy (gels, sports drinks used outside of training windows) or poor post-workout carbohydrate timing that transiently floods the SGLT2 transporter.

Adults Over 60

Age-related sarcopenia reduces the muscle mass available for GLUT4-mediated postprandial glucose uptake, which is why postprandial glucose excursions tend to worsen with age even in people who remain active. A 2020 study in Nutrients (N=1,247) found that appendicular skeletal muscle mass index was independently associated with 1,5-AG after controlling for age, sex, BMI, and HbA1c. Resistance training that preserves or builds muscle mass is therefore the highest-yield intervention for GlycoMark optimization in this population.

People With Prediabetes (HbA1c 5.7 to 6.4%)

For people in the prediabetic range, 1,5-AG typically falls between 10.0 and 17.0 mcg/mL and is one of the most sensitive markers for monitoring lifestyle intervention response. The Diabetes Prevention Program (DPP, N=3,234) demonstrated that 150 minutes of moderate weekly activity reduced progression to type 2 diabetes by 58% over 2.8 years. While the DPP did not track 1,5-AG directly, subsequent re-analysis cohorts have shown that individuals who achieved the DPP activity target showed 1,5-AG increases averaging 3.5 to 4.5 mcg/mL over 6 months, moving many out of the high-excursion zone.